z-logo
open-access-imgOpen Access
Granulocyte Macrophage Colony-Stimulating Factor in 66 Patients with Myeloid or Lymphoid Neoplasms and Recipients of Hematopoietic Stem Cell Transplantation with Invasive Fungal Disease
Author(s) -
Amar Safdar,
Gilhen Rodriguez,
Jorge M. Zuñiga,
Fadi Al Akhrass,
Georgia Georgescu,
Anupam Pande
Publication year - 2012
Publication title -
acta haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.574
H-Index - 56
eISSN - 1421-9662
pISSN - 0001-5792
DOI - 10.1159/000342121
Subject(s) - neutropenia , medicine , gastroenterology , hematopoietic stem cell transplantation , granulocyte colony stimulating factor , transplantation , myeloid , immunology , granulocyte macrophage colony stimulating factor , toxicity , chemotherapy , cytokine
Adding granulocyte macrophage colony-stimulating factor (GM-CSF) may improve the response to antifungal therapy in immunosuppressed patients with invasive fungal disease (IFD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom